The Board of Directors of RAMINFO Limited in its meeting held on 10th January 2022 at 05.30 PM had resolved to subscribe to 50 units of Compulsory Convertible Preference Shares of KARKINOS HEALTHCARE PRIVATE LIMITED (CIN:U93090MH2020PTC342527) which are being offered at Face Value INR 10/- and premium of INR 2,24,990/- amounting to INR 2,25,000/- each.
RAMINFO intend collaborate closely with Karkinos to strengthen Healthcare vertical by leveraging Karkinos hybrid "hub and spoke" model, with owned specialized centers of clinical excellence and a distributed network of partners for last mile reach and delivery of care. A robust technology backbone, with clinical decision support systems, ensures high quality service delivery that focuses on the patient's well- being.
Karkinos Healthcare Private Ltd (KH), founded in July 2020, is technology driven, oncology focused, managed health care platform. Our mission is to ensure no person is deprived of quality care either by lack of access or affordability. KH has been founded by Mr. R Venkataramanan, former Managing Trustee of the Tata Trusts (ex-board member of Tata Memorial Hospital, Tata Medical Centre Trust; Tata Centres for cancer care).
A strong clinician team is led by Dr Moni Abraham K. (ex Director CCRC, Narayana Health, visiting professor Roswell Park Cancer Institute, NYU) and Dr. R. Sankaranarayanan (former Chief of Cancer Screening Group, Early Detection & Prevention Section and Special Advisor on Cancer Control at the International Agency for Research on Cancer, WHO).
Karkinos is backed by the Tata Group, Mr. Ratan Tata, Rakuten Medical Inc, a leading global biotech in oncology and several prominent institutions and individuals in India and abroad. Karkinos is proud to collaborate with Tata Memorial Hospital, UK's Guys and St Thomas NHS Foundation Trust and has several research collaborations with leading academic institutions in the United States to ensure we are at the frontier of oncology treatment and care. The company also has several professionals of eminence in cancer care as part of its Global Scientific Advisory Board.
The Turnover of KH is INR 0.36 lakhs as on 31st March 2021.
Shares of RAMINFO LIMITED was last trading in BSE at Rs. 147.20 as compared to the previous close of Rs. 147.30. The total number of shares traded during the day was 75902 in over 868 trades.
The stock hit an intraday high of Rs. 154.00 and intraday low of 140.00. The net turnover during the day was Rs. 11220188.00.